EFFECT OF DOPAMINERGIC MEDICATION ON RISK PREFERENCE IN PARKINSON'S DISEASE

被引：0
|
作者：
Mandali, Alekhya [1 ]
Chaudhuri, Ray [2 ]
Rizos, Alexandra [2 ]
Voon, Valerie [1 ]
机构：
[1] Univ Cambridge, Dept Psychiat, Cambridge, England
[2] Kings Coll London, Ctr Excellence Parkinsons & Movement Disorders, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷
关键词：
D O I：
10.1136/jnnp-2019-BNPA.43
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
43
引用
收藏
页码：A20 / A21
页数：2
相关论文
共 50 条
  • [31] Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease
    Fern-Pollak, L
    Whone, AL
    Brooks, DJ
    Mehta, MA
    NEUROPSYCHOLOGIA, 2004, 42 (14) : 1917 - 1926
  • [32] Dopaminergic Medication Impairs Learning but not Decision Making in Parkinson's Disease
    Vo, Andrew
    Hiebert, Nole M.
    Seergobin, Ken N.
    Solcz, Stephanie
    Partridge, Allison
    MacDonald, Penny A.
    CANADIAN JOURNAL OF EXPERIMENTAL PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE EXPERIMENTALE, 2014, 68 (04): : 271 - 271
  • [33] Motivational modulation of bradykinesia in Parkinson's disease off and on dopaminergic medication
    Kojovic, Maja
    Mir, Pablo
    Trender-Gerhard, Iris
    Schneider, Susanne A.
    Parees, Isabel
    Edwards, Mark J.
    Bhatia, Kailash P.
    Jahanshahi, Marjan
    JOURNAL OF NEUROLOGY, 2014, 261 (06) : 1080 - 1089
  • [34] Theory of mind deficits in Parkinson's disease are not modulated by dopaminergic medication
    Usnich, Tatiana
    Krasivskaya, Elena
    Klostermann, Fabian
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [35] The effects of dopaminergic medication on dynamic decision making in Parkinson's disease
    Osman, Magda
    Ryterska, Agata
    Karimi, Kash
    Tu, LingLing
    Obeso, Ignacio
    Speekenbrink, Maarten
    Jahanshahi, Marjan
    NEUROPSYCHOLOGIA, 2014, 53 : 157 - 164
  • [36] Dopaminergic Medication-Related Repetitive Behaviors in Parkinson's Disease
    Baik, Jong Sam
    Han, Sang Won
    Kim, Jeong Yeon
    Park, Jae Hyeon
    JOURNAL OF MOVEMENT DISORDERS, 2008, 1 (02) : 101 - 103
  • [37] Dopaminergic medication alters auditory distractor processing in Parkinson's disease
    Georgiev, Dejan
    Jahanshahi, Marjan
    Dreo, Jurij
    Cus, Anja
    Pirtosek, Zvezdan
    Repovs, Grega
    ACTA PSYCHOLOGICA, 2015, 156 : 45 - 56
  • [38] Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson's Disease
    El Haddouchi, M.
    Handberg, A.
    Svaerke, K.
    Loekkegaard, A.
    MOVEMENT DISORDERS, 2019, 34 : S634 - S634
  • [39] Clinical subtype and response to dopaminergic medication in early Parkinson's disease
    Morrison, R.
    Newman, E. J.
    SCOTTISH MEDICAL JOURNAL, 2013, 58 (03) : E50 - E51
  • [40] Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease
    Miller, Nathaniel S.
    Chou, Kelvin L.
    Bohnen, Nicolaas I.
    Mueller, Martijn L. T. M.
    Seidler, Rachael D.
    PARKINSONISM & RELATED DISORDERS, 2018, 48 : 54 - 60
12345